Cancer statistics: Current diagnosis and treatment of pancreatic cancer in Shanghai, China

详细信息    查看全文

• 作者：Jiang Long^a ; ^b ; ^c ; ¹ ; Guo-pei Luo^a ; ^b ; ^c ; ¹ ; Zhi-wen Xiao^a ; ^b ; ^c ; ¹ ; Zu-qiang Liu^a ; ^b ; ^c ; Meng Guo^a ; ^b ; ^c ; Liang Liu^a ; ^b ; ^c ; Chen Liu^a ; ^b ; ^c ; Jin Xu^a ; ^b ; ^c ; Yu-tang Gao^e ; Ying Zheng^f ; Chunxiao Wu^f ; Quan-xing Ni^a ; ^b ; ^c ; Min Li^a ; ^b ; ^c ; ^d ; ^{min.li@uth.tmc.edu" class="auth_mail} ; Xianjun Yu^a ; ^b ; ^c ; ^{yuxianjun88@hotmail.com" class="auth_mail}
• 关键词：Pancreatic cancer ; Shanghai ; Prognosis ; Survival
• 刊名：Cancer Letters
• 出版年：1 May, 2014
• 年：2014
• 卷：346
• 期：2
• 页码：273-277
• 全文大小：1167 K

文摘

A multi-center population-based study in Shanghai, China was performed to explore the implications for the management of pancreatic cancer by comparing diagnosis and survival rates. Novel imaging modalities including MRI (13.9%), PET/CT (1.8%), and EUS (5.6%) were not widely used in our population. Only 39.7% of cases were histologically verified (surgery with histologic diagnosis 31.0%, cytological diagnosis 8.7%, surgery without histologic diagnosis 12.1%, and clinical diagnosis 48.2%). Overall, 30.0% of patients underwent curative-intent operation, and only 9.8% of patients received comprehensive treatment. The prognosis of pancreatic cancer patients was significantly better for patients who were treated in high-volume centers than in low-volume centers. We propose that more effort should be put on novel diagnostic modalities, histological confirmation, and comprehensive treatment in China. Multidisciplinary teams specialized in pancreatic cancer therapy in high-volume centers are urgently needed.